Belgium Country Drug Report 2019

Drug-related research

In Belgium, the responsibilities for research are divided between Belgium’s Communities and the federal state. The budget for scientific research in the drugs field is provided under the Federal Drug Policy Note and is managed by the Belgian Federal Science Policy Office (BELSPO) through a research programme that supports federal policy. Most studies funded through this programme are carried out by networks of researchers. The national focal point for the EMCDDA may also be a partner in these studies and is often involved in guidance committees. In addition, the national focal point collects information on ongoing and completed studies in Belgium and disseminates information on drug-related research findings to different audiences through a variety of channels.

Recent drug-related research in Belgium includes population-based and clinical studies of epidemiology, treatment interventions and drug market analysis. Drug-related research is frequently published in national and international scientific journals.

Belgium main page

Methodological note: Analysis of trends is based only on those countries providing sufficient data to describe changes over the period specified. The reader should also be aware that monitoring patterns and trends in a hidden and stigmatised behaviour like drug use is both practically and methodologically challenging. For this reason, multiple sources of data are used for the purposes of analysis in this report. Caution is therefore required in interpretation, in particular when countries are compared on any single measure. Detailed information on methodology and caveats and comments on the limitations in the information set available can be found in the EMCDDA Statistical Bulletin.